These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 12073810)
21. [New antiplatelet agents (platelet receptor blockers): has aspirin come out of place?]. Tsakiris DA Praxis (Bern 1994); 2004 Jun; 93(23):1003-5. PubMed ID: 15233569 [No Abstract] [Full Text] [Related]
22. Antiplatelet therapy in percutaneous coronary intervention: a critical review of the 2007 AHA/ACC/SCAI guidelines and beyond. Cohen M Catheter Cardiovasc Interv; 2009 Oct; 74(4):579-97. PubMed ID: 19472347 [TBL] [Abstract][Full Text] [Related]
23. Optimizing long-term dual aspirin/clopidogrel therapy in acute coronary syndromes: when does the risk outweigh the benefit? Collet JP; Montalescot G Int J Cardiol; 2009 Mar; 133(1):8-17. PubMed ID: 19187982 [TBL] [Abstract][Full Text] [Related]
24. [Combination is standard. Dual thrombocyte function inhibition in acute coronary syndrome]. MMW Fortschr Med; 2004; 146 Suppl 1():8-9. PubMed ID: 15493411 [No Abstract] [Full Text] [Related]
25. Perioperative management of antiplatelet agents in patients undergoing cardiac surgery. Lavi S; Lavi R J Cardiothorac Vasc Anesth; 2012 Aug; 26(4):680-6. PubMed ID: 22534412 [No Abstract] [Full Text] [Related]
26. Clopidogrel and proton pump inhibitor use: what does the evidence really say? Baker WL; Coleman CI; Lundbye JB Conn Med; 2010 Jan; 74(1):27-31. PubMed ID: 20175370 [No Abstract] [Full Text] [Related]
28. Use of antiplatelet drugs after cardiac operations. Ferraris VA; Bolanos MD Semin Thorac Cardiovasc Surg; 2014; 26(3):223-30. PubMed ID: 25527016 [TBL] [Abstract][Full Text] [Related]
29. Pro: continuation of aspirin/clopidogrel for cardiac surgery. van der Linden J J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):602-5. PubMed ID: 17678798 [No Abstract] [Full Text] [Related]
30. Clopidogrel and proton pump inhibitors: influence of pharmacological interactions on clinical outcomes and mechanistic explanations. Tantry US; Kereiakes DJ; Gurbel PA JACC Cardiovasc Interv; 2011 Apr; 4(4):365-80. PubMed ID: 21511216 [TBL] [Abstract][Full Text] [Related]
31. [Interview with Prof. Dr. H. J. Rupprecht about secondary prevention: what is the optimal thrombocyte function inhibition?]. Rupprecht HJ MMW Fortschr Med; 2004; 146 Suppl 1():9-10. PubMed ID: 15493412 [No Abstract] [Full Text] [Related]
38. [Clopidogrel and proton pump inhibitors--boon or bane?]. Labenz J; Meyners W; Petersen KU Dtsch Med Wochenschr; 2010 Feb; 135(5):203-6. PubMed ID: 20104441 [No Abstract] [Full Text] [Related]
39. Antiplatelet therapy in acute coronary syndromes: beyond aspirin and clopidogrel. Curzen N Heart; 2012 Nov; 98(22):1617-9. PubMed ID: 22801999 [No Abstract] [Full Text] [Related]
40. Using a FOCUS-PDCA quality improvement model for applying the severe traumatic brain injury guidelines to practice: process and outcomes. Bader MK; Palmer S; Stalcup C; Shaver T Reflect Nurs Leadersh; 2002; 28(2):34-5. PubMed ID: 12073809 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]